209 related articles for article (PubMed ID: 32893977)
1. Targeting UDP-glucose dehydrogenase inhibits ovarian cancer growth and metastasis.
Lin LH; Chou HC; Chang SJ; Liao EC; Tsai YT; Wei YS; Chen HY; Lin MW; Wang YS; Chien YA; Yu XR; Chan HL
J Cell Mol Med; 2020 Oct; 24(20):11883-11902. PubMed ID: 32893977
[TBL] [Abstract][Full Text] [Related]
2. UDP-glucose accelerates SNAI1 mRNA decay and impairs lung cancer metastasis.
Wang X; Liu R; Zhu W; Chu H; Yu H; Wei P; Wu X; Zhu H; Gao H; Liang J; Li G; Yang W
Nature; 2019 Jul; 571(7763):127-131. PubMed ID: 31243371
[TBL] [Abstract][Full Text] [Related]
3. Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells.
Zhang R; Shi H; Chen Z; Wu Q; Ren F; Huang H
J Exp Clin Cancer Res; 2011 Sep; 30(1):83. PubMed ID: 21923915
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control.
Grassi ML; Palma CS; Thomé CH; Lanfredi GP; Poersch A; Faça VM
J Proteomics; 2017 Jan; 151():2-11. PubMed ID: 27394697
[TBL] [Abstract][Full Text] [Related]
5. UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancer.
Harrington BS; Kamdar R; Ning F; Korrapati S; Caminear MW; Hernandez LF; Butcher D; Edmondson EF; Traficante N; Hendley J; ; Gough M; Rogers R; Lourie R; Shetty J; Tran B; Elloumi F; Abdelmaksoud A; Nag ML; Mazan-Mamczarz K; House CD; Hooper JD; Annunziata CM
J Exp Clin Cancer Res; 2023 Oct; 42(1):270. PubMed ID: 37858159
[TBL] [Abstract][Full Text] [Related]
6. Human chorionic gonadotropin β regulates epithelial-mesenchymal transition and metastasis in human ovarian cancer.
Liu N; Peng SM; Zhan GX; Yu J; Wu WM; Gao H; Li XF; Guo XQ
Oncol Rep; 2017 Sep; 38(3):1464-1472. PubMed ID: 28713970
[TBL] [Abstract][Full Text] [Related]
7. UDP-glucose dehydrogenase expression is upregulated following EMT and differentially affects intracellular glycerophosphocholine and acetylaspartate levels in breast mesenchymal cell lines.
Wang Q; Karvelsson ST; Johannsson F; Vilhjalmsson AI; Hagen L; de Miranda Fonseca D; Sharma A; Slupphaug G; Rolfsson O
Mol Oncol; 2022 May; 16(9):1816-1840. PubMed ID: 34942055
[TBL] [Abstract][Full Text] [Related]
8. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated glucuronic acid metabolism exacerbates hepatocellular carcinoma progression and metastasis through the TGFβ signalling pathway.
Gao Q; Cheng B; Chen C; Lei C; Lin X; Nie D; Li J; Huang L; Li X; Wang K; Huang A; Tang N
Clin Transl Med; 2022 Aug; 12(8):e995. PubMed ID: 35979621
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and prognostic significance of nuclear UGDH localization in lung adenocarcinoma.
Hagiuda D; Nagashio R; Ichinoe M; Tsuchiya B; Igawa S; Naoki K; Satoh Y; Murakumo Y; Saegusa M; Sato Y
Biomed Res; 2019; 40(1):17-27. PubMed ID: 30787260
[TBL] [Abstract][Full Text] [Related]
12. Arenobufagin, isolated from toad venom, inhibited epithelial-to-mesenchymal transition and suppressed migration and invasion of lung cancer cells via targeting IKKβ/NFκB signal cascade.
Zhao J; Zhang Q; Zou G; Gao G; Yue Q
J Ethnopharmacol; 2020 Mar; 250():112492. PubMed ID: 31866511
[TBL] [Abstract][Full Text] [Related]
13. TNNC1 knockout reverses metastatic potential of ovarian cancer cells by inactivating epithelial-mesenchymal transition and suppressing F-actin polymerization.
Yin JH; Elumalai P; Kim SY; Zhang SZ; Shin S; Lee M; Chung YJ
Biochem Biophys Res Commun; 2021 Apr; 547():44-51. PubMed ID: 33592378
[TBL] [Abstract][Full Text] [Related]
14. E2F8 Induces Cell Proliferation and Invasion through the Epithelial-Mesenchymal Transition and Notch Signaling Pathways in Ovarian Cancer.
Eoh KJ; Kim HJ; Lee JW; Kim LK; Park SA; Kim HS; Kim YT; Koo PJ
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823614
[TBL] [Abstract][Full Text] [Related]
15. MiR-15a-3p suppresses the growth and metastasis of ovarian cancer cell by targeting Twist1.
Fan B; Chen LP; Yuan YH; Xiao HN; Lv XS; Xia ZY
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1934-1946. PubMed ID: 30915736
[TBL] [Abstract][Full Text] [Related]
16. Regulation of UDP-glucose dehydrogenase is sufficient to modulate hyaluronan production and release, control sulfated GAG synthesis, and promote chondrogenesis.
Clarkin CE; Allen S; Kuiper NJ; Wheeler BT; Wheeler-Jones CP; Pitsillides AA
J Cell Physiol; 2011 Mar; 226(3):749-61. PubMed ID: 20717929
[TBL] [Abstract][Full Text] [Related]
17. Initial Identification of UDP-Glucose Dehydrogenase as a Prognostic Marker in Breast Cancer Patients, Which Facilitates Epirubicin Resistance and Regulates Hyaluronan Synthesis in MDA-MB-231 Cells.
Vitale DL; Caon I; Parnigoni A; Sevic I; Spinelli FM; Icardi A; Passi A; Vigetti D; Alaniz L
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33572239
[TBL] [Abstract][Full Text] [Related]
18. Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer.
Chen L; Yao Y; Sun L; Zhou J; Miao M; Luo S; Deng G; Li J; Wang J; Tang J
Cell Physiol Biochem; 2017; 43(6):2489-2504. PubMed ID: 29131012
[TBL] [Abstract][Full Text] [Related]
19. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
[No Abstract] [Full Text] [Related]
20. Angiotensin II type 2 receptor-interacting protein 3a inhibits ovarian carcinoma metastasis via the extracellular HMGA2-mediated ERK/EMT pathway.
Ping H; Guo L; Xi J; Wang D
Tumour Biol; 2017 Jun; 39(6):1010428317713389. PubMed ID: 28651497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]